P2‐644: SAFETY, TOLERABILITY, AND LIFESTYLE CHANGES ASSOCIATED WITH APOE DISCLOSURE IN THE BUTLER ALZHEIMER'S PREVENTION REGISTRY: IMPLICATIONS FOR RECRUITMENT TO CLINICAL TRIALS. (1st July 2006)